|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2004-4-22
|
|
pubmed:abstractText |
CD55 is a complement regulatory protein expressed by cells to protect them from bystander attack by complement. CD55 is overexpressed on some tumor cell lines, and in colorectal carcinomas, it has been shown to be an indicator of poor prognostic.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2797-803
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15102687-Animals,
pubmed-meshheading:15102687-Antibodies, Monoclonal,
pubmed-meshheading:15102687-Antigens, CD55,
pubmed-meshheading:15102687-Antigens, CD59,
pubmed-meshheading:15102687-Blotting, Western,
pubmed-meshheading:15102687-Breast Neoplasms,
pubmed-meshheading:15102687-Carcinoma,
pubmed-meshheading:15102687-Cell Line, Tumor,
pubmed-meshheading:15102687-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:15102687-Humans,
pubmed-meshheading:15102687-Immunohistochemistry,
pubmed-meshheading:15102687-Mice,
pubmed-meshheading:15102687-Mice, Inbred BALB C,
pubmed-meshheading:15102687-Peptides,
pubmed-meshheading:15102687-Prognosis,
pubmed-meshheading:15102687-Time Factors,
pubmed-meshheading:15102687-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Loss of CD55 is associated with aggressive breast tumors.
|
|
pubmed:affiliation |
Cancer Research UK Academic Unit of Clinical Oncology, University of Nottingham, City Hospital, Nottingham, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
